Veeva DQS Transforms Clinical Research with Unmatched Data Quality
In an era where clinical trials are generating unprecedented amounts of data, Veeva Systems is rising to the occasion. Their revolutionary platform, Veeva DQS (Data Quality System), has successfully aggregated and cleaned data for over 1 million subjects involved in more than 1,000 clinical studies. This significant achievement not only accelerates data analysis but also enhances trial insights crucial for the development of healthcare innovations.
Addressing the Challenges of Data Management
The ever-growing volume of clinical data is a challenge for research teams, often leading to inefficiencies in data management processes. Ibrahim Kamstrup-Akkaoui, Vice President at Novo, highlighted the critical need for tools that can manage, format, and prepare data for regulatory submissions efficiently. Veeva DQS stands out by automating the complex process of data reconciliation, thus saving an immense amount of time and resources.
Advanced Automation Features
Veeva DQS features over 500,000 automated queries, drastically reducing the hours spent on manual reconciliation tasks for sites and sponsors. This streamlined workflow allows clinical teams to focus more on decision-making and less on administrative duties. By improving data workflows, the system ensures that researchers can gain access to high-quality data more quickly, which is essential for making timely decisions in clinical settings.
Moreover, Veeva DQS empowers users to implement risk-based quality management (RBQM) strategies as recommended by regulatory guidelines such as ICH E6(R3). This approach strengthens the overall monitoring of clinical trials by enabling real-time alerts for data discrepancies, such as protocol deviations, helping teams to act decisively and manage risk effectively.
Integration of AI for Enhanced Data Classification
Additionally, the integration of data- and user-aware artificial intelligence within Veeva DQS elevates the classification process of study data. This advanced feature not only speeds up data assessment but also allows the system to tailor reports, listings, and test scripts according to specific user roles, thus enhancing user experience significantly. By understanding the purpose and criticality of data, Veeva DQS transforms the traditional approach to data management in clinical trials.
Expanding Horizons in Data Management
As the complexity of clinical protocols increases, sponsors and contract research organizations (CROs) are turning to Veeva DQS for scalable data automation. Pavel Burmenko, who leads Veeva DQS strategy, remarked on how the system is ushering a new wave of clinical data management innovation. This innovation not only simplifies the data management process but also redefines the role of data managers, enabling them to become strategic partners in the trial process.
Upcoming Innovations
This autumn, Veeva will introduce the
Study Builder Agent, a new tool designed to configure Veeva's Electronic Data Capture (EDC) and DQS directly from study protocols. This will further ensure that study builds are executed more consistently and swiftly, thereby enhancing the efficiency of clinical trials.
The drive towards automation and innovation continues with Veeva’s upcoming
RD and Quality Summit scheduled for October 20-21 in Boston. This event will showcase Veeva DQS’s capabilities and contributions to biopharmaceutical advancements, emphasizing its role in prompting clinical data innovations.
Conclusion
In conclusion, Veeva Systems is at the forefront of transforming how clinical trials manage and interpret vast data sets. By utilizing Veeva DQS, organizations can not only keep pace with the escalating volume of clinical data but also enhance the integrity and speed of their research efforts. The pharmaceutical industry is on the cusp of significant changes, and Veeva DQS is leading the way to a future where clinical data management is streamlined and effective.
For more information about Veeva and its innovative solutions, please visit
veeva.com.